Homologous Recombination Related Signatures Predict Prognosis and Immunotherapy Response in Metastatic Urothelial Carcinoma

Objective: This study used homologous recombination (HR) related signatures to develop a clinical prediction model for screening immune checkpoint inhibitors (ICIs) advantaged populations and identify hub genes in advanced metastatic urothelial carcinoma. Methods: The single-sample gene enrichment a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pan, Chen, Chaohu, Li, Jianpeng, Yang, Li, Wang, Yuhan, Dong, Zhilong, Mi, Jun, Zhang, Yunxin, Wang, Juan, Wang, Hanzhang, Rodriguez, Ronald, Tian, Junqiang, Wang, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086193/
https://www.ncbi.nlm.nih.gov/pubmed/35559013
http://dx.doi.org/10.3389/fgene.2022.875128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086193/
https://www.ncbi.nlm.nih.gov/pubmed/35559013
http://dx.doi.org/10.3389/fgene.2022.875128

Ejemplares similares